Recent articles​
All our articles

Polymorphism is a essential information !

According to ICH Q6A, polymorphism is described as:

« The occurence of different crystalline forms of the same drug substance. This may include solvation or hydration products (also know as pseudopolymorphs) and amorphous forms. »

Polymorphism is essential in pharma development for lead selection, solid form selection, regulatory affairs, IP, crystallization process development, robustness, and more.

Search
Contact us

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.